ES2286447T3 - Extrusion de masas fundidas de sales de sustancias activas. - Google Patents

Extrusion de masas fundidas de sales de sustancias activas. Download PDF

Info

Publication number
ES2286447T3
ES2286447T3 ES03742925T ES03742925T ES2286447T3 ES 2286447 T3 ES2286447 T3 ES 2286447T3 ES 03742925 T ES03742925 T ES 03742925T ES 03742925 T ES03742925 T ES 03742925T ES 2286447 T3 ES2286447 T3 ES 2286447T3
Authority
ES
Spain
Prior art keywords
hydrochloride
weight
active substance
sulfate
acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03742925T
Other languages
English (en)
Spanish (es)
Inventor
Hans-Ulrich Petereit
Christian Meier
Andreas Gryczke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Evonik Roehm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm GmbH filed Critical Evonik Roehm GmbH
Application granted granted Critical
Publication of ES2286447T3 publication Critical patent/ES2286447T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seasonings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
ES03742925T 2002-02-27 2003-01-30 Extrusion de masas fundidas de sales de sustancias activas. Expired - Lifetime ES2286447T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208344 2002-02-27
DE10208344A DE10208344A1 (de) 2002-02-27 2002-02-27 Schmelzextrusion von Wirkstoffsalzen

Publications (1)

Publication Number Publication Date
ES2286447T3 true ES2286447T3 (es) 2007-12-01

Family

ID=27675020

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03742925T Expired - Lifetime ES2286447T3 (es) 2002-02-27 2003-01-30 Extrusion de masas fundidas de sales de sustancias activas.

Country Status (14)

Country Link
US (1) US8642089B2 (de)
EP (1) EP1478344B1 (de)
JP (1) JP5054278B2 (de)
KR (1) KR100707712B1 (de)
AT (1) ATE362754T1 (de)
AU (1) AU2003210196A1 (de)
BR (1) BRPI0307995B8 (de)
CA (1) CA2474691C (de)
DE (2) DE10208344A1 (de)
ES (1) ES2286447T3 (de)
IL (2) IL162082A0 (de)
MX (1) MXPA04008345A (de)
PL (1) PL204465B1 (de)
WO (1) WO2003072083A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10239999A1 (de) * 2002-08-27 2004-03-04 Röhm GmbH & Co. KG Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen
DE10304403A1 (de) 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
JP2006028028A (ja) * 2004-07-12 2006-02-02 Teikoku Medix Kk 経口医薬組成物
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
ATE482690T1 (de) * 2005-12-14 2010-10-15 Hoffmann La Roche Hcv-prodrug-formulierung
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
US20100172989A1 (en) * 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
DE102007009242A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
CA2712010A1 (en) * 2008-01-11 2009-07-12 Cipla Limited Solid pharmaceutical dosage form
TW200950776A (en) * 2008-01-24 2009-12-16 Abbott Gmbh & Co Kg Abuse resistant melt extruded formulation having reduced alcohol interaction
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
KR101753222B1 (ko) 2014-12-12 2017-07-04 강원대학교산학협력단 용융압출하여 제조된 당귀-고체분산체 및 그 제조방법
WO2018111459A1 (en) * 2016-12-14 2018-06-21 Dow Global Technologies Llc Method for generating salts of pharmaceutical active ingredients
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
AU2019275406B2 (en) 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
AU3404997A (en) * 1996-05-31 1998-01-05 Euro-Celtique S.A. Sustained release oxycodone formulations with no fed/fast effect
US6673367B1 (en) 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19958007A1 (de) 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
HU229344B1 (en) 2001-02-27 2013-11-28 Evonik Roehm Gmbh Coating and binding agent for pharmaceutical formulations with improved storage stability
DE10239999A1 (de) 2002-08-27 2004-03-04 Röhm GmbH & Co. KG Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen

Also Published As

Publication number Publication date
ATE362754T1 (de) 2007-06-15
IL162082A0 (en) 2005-11-20
CA2474691A1 (en) 2003-09-04
PL370426A1 (en) 2005-05-30
CA2474691C (en) 2011-04-19
WO2003072083A2 (de) 2003-09-04
DE50307321D1 (de) 2007-07-05
PL204465B1 (pl) 2010-01-29
EP1478344A2 (de) 2004-11-24
IL162082A (en) 2009-11-18
KR100707712B1 (ko) 2007-04-16
US8642089B2 (en) 2014-02-04
BR0307995A (pt) 2004-12-07
US20040253314A1 (en) 2004-12-16
WO2003072083A3 (de) 2004-04-08
JP2005526731A (ja) 2005-09-08
DE10208344A1 (de) 2003-09-04
BRPI0307995B1 (pt) 2019-02-26
BRPI0307995B8 (pt) 2021-05-25
JP5054278B2 (ja) 2012-10-24
AU2003210196A1 (en) 2003-09-09
MXPA04008345A (es) 2004-11-26
KR20040084936A (ko) 2004-10-06
EP1478344B1 (de) 2007-05-23

Similar Documents

Publication Publication Date Title
ES2528359T3 (es) Procedimiento para la producción de una forma medicamentosa oral con desintegración y puesta en libertad inmediatas de las sustancias activas
US11839684B2 (en) Mucoadhesive pharmaceutical composition and preparation method therefor
ES2639130T3 (es) Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración
JP7458317B2 (ja) 崩壊が改善された経口用固形製剤組成物及びその製造方法
ES2212633T3 (es) Empleo de polimeros hidrosolubles o dispersables en agua, que contienen polieter como agente de recubrimiento, aglutinante y/o producto auxiliar formador de pelicula en formas de presentacion farmaceuticas.
JP5646340B2 (ja) ポリマー性対イオンと活性成分との塩
US8642089B2 (en) Melt extrusion of salts of active ingredients
JP5775223B2 (ja) 口腔内速崩壊性錠剤用造粒物
Pandey et al. Oral disintegrating tablets: a review
CN108136032A (zh) 包含糖或糖醇、溶胀型粘合剂、崩解剂及高吸收性赋形剂的复合化造粒物及其制造方法
CN101528205A (zh) 布洛芬组合物
CN105007899A (zh) 用于提高生物利用度的口腔崩解片制剂
CN101262852A (zh) 稳定活性药物成分的组合物和方法
WO2017115764A1 (ja) 圧縮成型製剤
WO2004100883A2 (en) Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same
JP4192256B2 (ja) 非ステロイド系鎮痛薬
CN105025882A (zh) 熔融挤出而成的控释药物组合物及包含其的口服制剂
Arunachalam et al. Fast dissolving drug delivery system: A review
JP6461496B2 (ja) 解熱鎮痛製剤
EP2265259A1 (de) Rasch im mund zerfallende zusammensetzungen aus tramadol
Kataria et al. FAST DISSOLVING TABLETS: AN OVERVIEW
HK40082826A (en) Orally disintegrating tablet containing mirogabalin besilate
Arun Formulation and evaluation of fast dissolving tablets of ketoprofen
JP2019019147A (ja) 解熱鎮痛医薬品